Ruxolitinib Recruiting Phase 2 Trials for Non-sclerotic Cutaneous Chronic Graft-versus-host Disease Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03954236Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease